Author:
Xu Zijun,Zhang Dexing,Zhao Yang,Ghosh Arpita,Peiris David,Li Yiqi,Wong Samuel Yeung Shan
Abstract
Abstract
Background
Validated and comprehensive tools to measure treatment burden are needed for healthcare professionals to understand the treatment burden of patients in China. The study aimed to translate and validate the Chinese version of Patient Experience with Treatment and Self-management (PETS vs. 2.0) in patients with multimorbidity in primary care.
Methodology
The translation process of the 60-item PETS vs. 2.0 followed the Functional Assessment of Chronic Illness Therapy (FACIT) Translation, Formatting, and Testing Guidelines. Computer-assisted assessments were conducted in adult primary care patients with multimorbidity from three general out-patient clinics in Hong Kong. A sample of 502 patients completed the assessments from July to December 2023. Internal reliability was examined using Cronbach’s alphas for each domain of the PETS vs. 2.0. Concurrent validity was assessed through the correlations between different domains of PETS vs. 2.0 with established measures including quality of life, frailty, and depression. Confirmatory Factor Analysis (CFA) with maximum likelihood method was carried out to assess the construct validity.
Results
The mean age of participants was 64.9 years old and 56.2% were female. Internal consistency reliability was acceptable (alpha ≥ 0.70) for most domains. Higher scores of PETS domains were significantly correlated with worse quality of life, higher level of frailty, and more depressive symptoms (p < 0.05). In CFA, after setting the covariances on the error variances, the adjusted model revealed an acceptable model fit (χ2/df = 1.741; root mean square error of approximation (RMSEA) = 0.038; standardized root mean square residual (SRMR) = 0.058; comparative fit index (CFI) = 0.911; Tucker-Lewis Index (TLI) = 0.903). All standardized factor loadings were 0.30 or above. Significant positive correlations between the latent factors were found for all factor pairs (correlation coefficient < 0.8).
Conclusions
The Chinese version of PETS vs. 2.0 is a reliable and valid tool for assessing the perceived treatment burden in patients with multimorbidity in primary care. All domains and items in the original questionnaires were retained.
Funder
CUHK-TGI Joint Collaborative Research Fund
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Van Den Akker M, Buntinx F, Knottnerus JA (1996) Comorbidity or multimorbidity: what’s in a name? A review of literature. Eur J Gen Pract 2(2):65–70
2. Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M et al (2014) Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One 9(7):e102149. https://doi.org/10.1371/journal.pone.0102149
3. Chu T, Lau P, Cheng RS, Chan M, Liang J (2018) A study on the prevalence of multi-morbidities of diseases and utilisation of public healthcare services in the New Territories West area of Hong Kong. Hong Kong Pract 40(2):43–50
4. Hua J, Zhaoxin W, Aizhen G, Hanzhi Z, Wei L, Yuqin Z et al (2022) Patterns of multimorbidity in community health centres in Shanghai, China: a retrospective, cross-sectional study based on outpatient data from 2014 to 2018. BMJ Open 12(10):e048727. https://doi.org/10.1136/bmjopen-2021-048727
5. Chin WY, Choi EPH, Wan EYF, Lam CLK (2016) Health-related quality of life mediates associations between multi-morbidity and depressive symptoms in Chinese primary care patients. Fam Pract 33(1):61–68